Fengling Liu, Ph.D.

Affiliations: 
2007 Georgia State University, Atlanta, GA, United States 
Area:
Molecular Biology
Google:
"Fengling Liu"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Irene T. Weber grad student 2007 Georgia State
 (Kinetic and crystallographic studies of drug-resistant mutants of HIV -1 protease: Insights into the drug resistance mechanisms.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Liu F, Marquardt G, Kirschner AN, et al. (2010) Mapping the N-terminal residues of Epstein-Barr virus gp42 that bind gH/gL by using fluorescence polarization and cell-based fusion assays Journal of Virology. 84: 10375-10385
Liu F, Kovalevsky AY, Tie Y, et al. (2008) Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir. Journal of Molecular Biology. 381: 102-15
Sayer JM, Liu F, Ishima R, et al. (2008) Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease. The Journal of Biological Chemistry. 283: 13459-70
Kovalevsky AY, Chumanevich AA, Liu F, et al. (2007) Caught in the Act: the 1.5 A resolution crystal structures of the HIV-1 protease and the I54V mutant reveal a tetrahedral reaction intermediate. Biochemistry. 46: 14854-64
Kovalevsky AY, Liu F, Leshchenko S, et al. (2007) Corrigendum to "Ultra-high Resolution Crystal Structure of HIV-1 Protease Mutant Reveals Two Binding Sites for Clinical Inhibitor TMC114" [J. Mol. Biol. 363 (2006) 161-173] (DOI:10.1016/j.jmb.2006.08.007) Journal of Molecular Biology. 365: 901
Kovalevsky AY, Liu F, Leshchenko S, et al. (2006) Ultra-high resolution crystal structure of HIV-1 protease mutant reveals two binding sites for clinical inhibitor TMC114. Journal of Molecular Biology. 363: 161-73
Liu F, Kovalevsky AY, Louis JM, et al. (2006) Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation. Journal of Molecular Biology. 358: 1191-9
Kovalevsky AY, Tie Y, Liu F, et al. (2006) Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M. Journal of Medicinal Chemistry. 49: 1379-87
Liu F, Boross PI, Wang YF, et al. (2005) Kinetic, stability, and structural changes in high-resolution crystal structures of HIV-1 protease with drug-resistant mutations L24I, I50V, and G73S. Journal of Molecular Biology. 354: 789-800
Tie Y, Boross PI, Wang YF, et al. (2005) Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs. The Febs Journal. 272: 5265-77
See more...